Dropprint Genomics
DROPPRINTGENOMICS
YC S19 · Acquired by Immunai

Single Cell
Genomics
Reimagined

Revolutionary computational platform analyzing individual immune cells at unprecedented scale—reducing costs by 10x while unlocking insights impossible with traditional methods.

10×
Cost Efficiency
vs traditional methods
1M+
Immune Cells
analyzed & mapped
2019
Founded
Y Combinator S19
2021
Acquired
by Immunai
ABOUT US

Transforming Drug Discovery Through Precision Biology

Founded in 2019 and backed by Y Combinator, we pioneered breakthrough software for single-cell genomics—investigating immune cells one at a time to accelerate pharmaceutical development.

Think of it like this: traditional methods average traffic speed across a highway. We measure every individual vehicle, identifying the exact speeding car instantly—unlocking cellular insights impossible to detect otherwise.

Following our acquisition by Immunai in 2021, our technology now powers the world's most comprehensive digital map of the human immune system.

First Movers

Pioneered million-cell analysis

Speed

Real-time computational processing

Scale

Largest immune cell database

Precision

Single-cell resolution targeting

TECHNOLOGY

Computational Innovation

Advanced infrastructure combining machine learning with single-cell precision

Single Cell Analysis

Proprietary software profiles every gene in every cell, enabling precise analysis of individual cellular activity across millions of immune cells simultaneously.

PrecisionScalableReal-time

Comprehensive Database

First database of 1M+ immune cells spanning healthy, cancerous, and autoimmune conditions.

Machine Learning

Advanced models characterize immune systems across thousands of individuals at unprecedented scale.

Key Achievements

Processed and analyzed millions of immune cells—a first in genomics

Achieved 10-fold cost reduction in single-cell sequencing operations

Built infinitely scalable computational infrastructure for analysis

Pioneered data-centric methodology for precise therapeutic targeting

FOUNDING TEAM

Led by World-Class
Scientists

Our founders emerged from the world's leading single-cell genomics laboratories, bringing decades of combined expertise in computational biology and machine learning.

Rachel Gate, PhD

Co-Founder & Chief Scientific Officer

PhD Bioinformatics, UCSF

Meena Subramaniam

Co-Founder & Head of Engineering

Computational Biology Expert

Jimmie Ye

Co-Founder & Scientific Advisor

Single Cell Genomics Pioneer

GET IN TOUCH

Let's Connect

Location
368 51st Street, Apartment A
Oakland, CA 94609
United States

Dropprint Genomics is now part of Immunai, where we continue revolutionizing immune system understanding and accelerating life-saving drug discovery.